Lipid management to reduce cardiovascular risk - A new strategy is required

被引：101

作者：

Superko, H. Robert ^{[1
]}

King, Spencer, III ^{[1
]}

机构：

[1] St Josephs Translat Res Inst, Ctr Genom & Human Hlth, Atlanta, GA 30342 USA

来源：

CIRCULATION | 2008年 / 117卷 / 04期

关键词：

D O I：

10.1161/CIRCULATIONAHA.106.667428

中图分类号：

R5 [内科学];

学科分类号：

1002 [临床医学]; 100201 [内科学];

摘要：

引用

收藏

页码：560 / 568

页数：9

相关论文

共 58 条

[1]

INFLUENCE OF NICOTINIC ACID ON SERUM CHOLESTEROL IN MAN [J].

ALTSCHUL, R ;

HOFFER, A ;

STEPHEN, JD .

ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1955, 54 (02) :558-559

[2]

Progression of coronary artery disease predicts clinical coronary events - Long-term follow-up from the Cholesterol Lowering Atherosclerosis Study [J].

Azen, SP ;

Mack, WJ ;

CashinHemphill, L ;

LaBree, L ;

Shircore, AM ;

Selzer, RH ;

Blankenhorn, DH ;

Hodis, HN .

CIRCULATION, 1996, 93 (01) :34-41

[3]

Comparison of once-daily, niacin extended/release/lovastatin with standard doses of atorvastatin and simvastafin (The Advicor Versus Other Cholesterol-Modulating Agents Trial Evaluation [ADVOCATE]) [J].

Bays, HE ;

Dujovne, CA ;

McGovern, ME ;

White, TE ;

Kashyap, ML ;

Hutcheson, AG ;

Crouse, JR .

AMERICAN JOURNAL OF CARDIOLOGY, 2003, 91 (06) :667-672

[4]

CHARACTERIZATION OF HUMAN HIGH-DENSITY LIPOPROTEINS BY GRADIENT GEL-ELECTROPHORESIS [J].

BLANCHE, PJ ;

GONG, EL ;

FORTE, TM ;

NICHOLS, AV .

BIOCHIMICA ET BIOPHYSICA ACTA, 1981, 665 (03) :408-419

[5]

CORONARY ANGIOGRAPHIC CHANGES WITH LOVASTATIN THERAPY - THE MONITORED ATHEROSCLEROSIS REGRESSION STUDY (MARS) [J].

BLANKENHORN, DH ;

AZEN, SP ;

KRAMSCH, DM ;

MACK, WJ ;

CASHINHEMPHILL, L ;

HODIS, HN ;

DEBOER, LWV ;

MAHRER, PR ;

MASTELLER, MJ ;

VAILAS, LI ;

ALAUPOVIC, P ;

HIRSCH, LJ .

ANNALS OF INTERNAL MEDICINE, 1993, 119 (10) :969-976

[6]

Regulation of plasma high-density lipoprotein levels by the ABCA1 transporter and the emerging role of high-density lipoprotein in the treatment of cardiovascular disease [J].

Brewer, HB ;

Remaley, AT ;

Neufeld, EB ;

Basso, F ;

Joyce, C .

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2004, 24 (10) :1755-1760

[7]

Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease [J].

Brown, BG ;

Zhao, XQ ;

Chait, A ;

Fisher, LD ;

Cheung, MC ;

Morse, JS ;

Dowdy, AA ;

Marino, EK ;

Bolson, EL ;

Alaupovic, P ;

Frohlich, J ;

Albers, JJ ;

Serafini, L ;

Huss-Frechette, E ;

Wang, S ;

DeAngelis, D ;

Dodek, A .

NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (22) :1583-1592

[8]

Brown BG, 1998, CIRCULATION, V98, P635

[9]

REGRESSION OF CORONARY-ARTERY DISEASE AS A RESULT OF INTENSIVE LIPID-LOWERING THERAPY IN MEN WITH HIGH-LEVELS OF APOLIPOPROTEIN-B [J].

BROWN, G ;

ALBERS, JJ ;

FISHER, LD ;

SCHAEFER, SM ;

LIN, JT ;

KAPLAN, C ;

ZHAO, XQ ;

BISSON, BD ;

FITZPATRICK, VF ;

DODGE, HT .

NEW ENGLAND JOURNAL OF MEDICINE, 1990, 323 (19) :1289-1298

[10]

PLASMA-LIPID, LIPOPROTEIN CHOLESTEROL, AND APOPROTEIN DISTRIBUTIONS IN SELECTED UNITED-STATES COMMUNITIES - THE ATHEROSCLEROSIS RISK IN COMMUNITIES (ARIC) STUDY [J].

BROWN, SA ;

HUTCHINSON, R ;

MORRISETT, J ;

BOERWINKLE, E ;

DAVIS, CE ;

GOTTO, AM ;

PATSCH, W .

ARTERIOSCLEROSIS AND THROMBOSIS, 1993, 13 (08) :1139-1158

← 1 2 3 4 5 6 →